BioNTech eyes catalyst-rich 2026 as it advances multi-product oncology strategy
BioNTech SE (BNTX) said Monday it will continue executing its strategy in 2026 to evolve into a multi-product oncology...
Tag: BNTX
CDC overhauls childhood vaccine schedule to recommend fewer shots
The Centers for Disease Control and Prevention (CDC) on Monday announced dramatic changes to the U.S. childhood vaccine...
FDA plans to put “black box” warning on Covid vaccines: report
The US Food and Drug Administration (FDA) plans to add a “black box” warning to COVID-19 vaccines, CNN reported, citing...
CDC study finds COVID shot significantly reduced ER visits for children
A fresh study authored by CDC scientists is throwing water on the argument that children do not need the COVID-19 vaccine....
Pfizer is reportedly shedding hundreds of jobs in Switzerland
Pfizer (PFE) is reducing its Swiss workforce, with plans to cut its employee count to about 70 by the end of 2025 from 300...
FDA expands COVID-19 shot safety probe to include adults – report
The US FDA is now investigating whether COVID-19 vaccines are tied to deaths in adults. The agency is "doing a thorough...
Former FDA commissioners castigate plan to change vaccine approval standards
A dozen former FDA commissioners have come together to pen a scathing op-ed opposing a plan recently unveiled by the...
Vaccine panel head who opposed COVID restrictions elevated to senior HHS role
Martin Kulldorff, a former Harvard Medical School professor who was fired from the institution after refusing to get a...
Moderna, vaccine makers decline following FDA official comments on future approvals
Moderna (MRNA) and other biopharma companies focused on developing vaccines are trading in the red on Monday following...
BioNTech’s exchange offer for German mRNA vaccine peer CureVac set to expire Dec. 3
BioNTech SE (BNTX) on Wednesday announced the approval of matters relating to the exchange offer for all outstanding shares...